Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: Correlation with histologic sections determinations and diagnostic pitfalls-Reference-Cited by-同舟云学术

Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: Correlation with histologic sections determinations and diagnostic pitfalls

Published:2004 Issue:4 Volume:30 Page:251-256
ISSN:8755-1039
Container-title:Diagnostic Cytopathology
language:en
Short-container-title:Diagn. Cytopathol.

Author:

Moriki Toshiaki,Takahashi Tamotsu,Ueta Shousuke,Mitani Miko,Ichien Miho

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Reference42 articles.

1. Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas

2. Immunocytochemical localization of estrogen and progesterone receptors in imprint preparations of breast carcinomas

3. Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry

4. Estimation of estrogen receptor content in fine-needle aspirates from breast cancer using the monoclonal antibody 1d5 and microwave oven processing: Correlation with paraffin embedded and frozen sections determinations

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Special Ancillary Techniques: Immunohistochemistry;Fine Needle Aspiration Cytology of the Breast;2023

2. Future Directions;Fine Needle Aspiration Cytology of the Breast;2023

3. Immunohistochemistry Applied to Breast Cytological Material;Pathobiology;2022

4. Evaluation of estrogen and progesterone receptors and Her-2 expression with grading in the fine-needle aspirates of patients with breast carcinoma;Journal of Cytology;2018

5. Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy;Oncotarget;2017-02-20